EU Panel Likes Azacitidine for AML Maintenance EU Panel Likes Azacitidine for AML Maintenance

The EMA ' s Committee for Medicinal Products for Human Use adopted a positive opinion of the drug for use as maintenance therapy in patients with acute myeloid leukemia.International Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news